From Wikipedia, the free encyclopedia



Users

Additions

  1. 2014-04-05 07:43:54 (UTC): w:sh:User:Dcirovicbot ( t - c; 1133185) to w:sh:Aplindor ( diff  !top) - Link: www.pharmaceutical-business-review.com/article_news.asp?guid=E6E77319-B0D6-4E6A-9288-DD43A553D2F9 ( R/ Xmeta/ L)
    Other links: www.pharmaceutical-business-review.com/article_news.asp?guid=E6E77319-B0D6-4E6A-9288-DD43A553D2F9 (1133185, 2, X, X- R/ X/ L) dx.doi.org/10.1002/(SICI)1097-0061(200004)17:1 (1133185, -1, X, X- R/ X/ L) onlinelibrary.wiley.com/doi/10.1002/%28SICI%291097-0061%28200004%2917:1%3C48::AID-YEA2%3E3.0.CO;2-H/full (1133185, -1, X, X- R/ X/ L) dx.doi.org/10.1186/1758-2946-2-3 (1133185, -1, X, X- R/ X/ L) www.jcheminf.com/content/2/1/3 (1133185, 9560, X, X- R/ X/ L) dx.doi.org/10.1016/S1574-1400(08)00012-1 (1133185, -1, X, X- R/ X/ L) dx.doi.org/10.1016/j.drudis.2010.10.003 (1133185, -1, X, X- R/ X/ L) www.sciencedirect.com/science/article/pii/S1359644610007737 (1133185, -1, X, X- R/ X/ L) pubchem.ncbi.nlm.nih.gov/search/?smarts=c4ccccc4CNCC%28CO2%29Oc1c2ccc%28N3%29c1CC3%3DO (1133185, -1, X, X- R/ X/ L) www.emolecules.com/cgi-bin/search?t=ex&q=c4ccccc4CNCC%28CO2%29Oc1c2ccc%28N3%29c1CC3%3DO (1133185, 4987, X, X- R/ X/ L) www.kegg.jp/entry/D03214 (1133185, 1992, X, X- R/ X/ L) fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=Q5O76TA0ML (1133185, -1, X, X- R/ X/ L) www.chemspider.com/Chemical-Structure.139676 (1133185, -1, X, X- R/ X/ L) pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=158784 (1133185, -1, X, X- R/ X/ L) www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=189681-71-8&rn=1 (1133185, -1, X, X- R/ X/ L)

    User is in a trusted group bot on some wikis
  2. 2014-04-06 15:30:06 (UTC): w:fr:User:Bob Saint Clar ( t - c; 3500) to w:fr:Peramivir ( diff  !top) - Link: drugdiscovery.pharmaceutical-business-review.com/news/shionogi_launches_rapiacta_in_japan_100126 ( R/ Xmeta/ L)
    Other links: drugdiscovery.pharmaceutical-business-review.com/news/shionogi_launches_rapiacta_in_japan_100126 (3500, 1, 1, 0- R/ X/ L) www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm216252.htm (3500, 1314, X, X- R/ X/ L) www.nejm.org/doi/full/10.1056/NEJMp0910479 (3500, 579, 2, 0- R/ X/ L) dx.doi.org/10.1056/NEJMp0910479 (3500, -1, X, X- R/ X/ L) www.ncbi.nlm.nih.gov/pubmed/19884645 (3500, -1, X, X- R/ X/ L) www.reuters.com/article/2009/10/24/idUS10540+24-Oct-2009+PRN20091024 (3500, -1, X, X- R/ X/ L) www.fda.gov/downloads/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm187811.pdf (3500, 1314, X, X- R/ X/ L) aac.asm.org/content/54/11/4568.short (3500, 113, 4, 0- R/ X/ L) dx.doi.org/10.1128/AAC.00474-10 (3500, -1, X, X- R/ X/ L) www.ncbi.nlm.nih.gov/pmc/articles/2976170 (3500, -1, X, X- R/ X/ L) www.ncbi.nlm.nih.gov/pubmed/20713668 (3500, -1, X, X- R/ X/ L) www.chem.qmul.ac.uk/iupac/AtWt/ (3500, -1, X, X- R/ X/ L) chemapps.stolaf.edu/jmol/jmol.php?title=Peramivir&model=InChI%3D1S%2FC15H28N4O4%2Fc1-4-8%285-2%2912%2818-7%283%2920%2911-10%2819-15%2816%2917%296-9%2813%2811%2921%2914%2822%2923%2Fh8-13%2C21H%2C4-6H2%2C1-3H3%2C%28H%2C18%2C20%29%28H%2C22%2C23%29%28H4%2C16%2C17%2C19%29%2Ft9-%2C10%2B%2C11%2B%2C12-%2C13%2B%2Fm0%2Fs1 (3500, -1, X, X- R/ X/ L) chemapps.stolaf.edu/jmol/jmol.php?title=Peramivir&model=CCC%28CC%29%5BC%40%40H%5D%28%5BC%40H%5D1%5BC%40%40H%5D%28C%5BC%40%40H%5D%28%5BC%40H%5D1O%29C%28%3DO%29O%29N%3DC%28N%29N%29NC%28%3DO%29C (3500, -1, X, X- R/ X/ L) pubchem.ncbi.nlm.nih.gov/search/?smarts=CCC%28CC%29%5BC%40%40H%5D%28%5BC%40H%5D1%5BC%40%40H%5D%28C%5BC%40%40H%5D%28%5BC%40H%5D1O%29C%28%3DO%29O%29N%3DC%28N%29N%29NC%28%3DO%29C (3500, -1, X, X- R/ X/ L) pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=154234 (3500, -1, X, X- R/ X/ L)
  3. 2014-04-09 16:16:46 (UTC): w:de:User:188.96.230.236 ( t - c; 13) to w:de:Ranbaxy Laboratories ( diff  !top) - Link: www.pharmaceutical-business-review.com/companyprofile.asp?guid=07C112BA-D49F-4A9E-9EB4-1630A9D4F8E6 ( R/ Xmeta/ L)
    Other links: www.pharmaceutical-business-review.com/companyprofile.asp?guid=07C112BA-D49F-4A9E-9EB4-1630A9D4F8E6 (13, 2, 1, 1- R/ X/ L) www.indiaprwire.com/pressrelease/ranbaxy/ (13, 91, 1, 1- R/ X/ L) www.ranbaxy.com/profile.htm (13, 8, 1, 1- R/ X/ L)
  • Displayed all 3 additions.
From Wikipedia, the free encyclopedia



Users

Additions

  1. 2014-04-05 07:43:54 (UTC): w:sh:User:Dcirovicbot ( t - c; 1133185) to w:sh:Aplindor ( diff  !top) - Link: www.pharmaceutical-business-review.com/article_news.asp?guid=E6E77319-B0D6-4E6A-9288-DD43A553D2F9 ( R/ Xmeta/ L)
    Other links: www.pharmaceutical-business-review.com/article_news.asp?guid=E6E77319-B0D6-4E6A-9288-DD43A553D2F9 (1133185, 2, X, X- R/ X/ L) dx.doi.org/10.1002/(SICI)1097-0061(200004)17:1 (1133185, -1, X, X- R/ X/ L) onlinelibrary.wiley.com/doi/10.1002/%28SICI%291097-0061%28200004%2917:1%3C48::AID-YEA2%3E3.0.CO;2-H/full (1133185, -1, X, X- R/ X/ L) dx.doi.org/10.1186/1758-2946-2-3 (1133185, -1, X, X- R/ X/ L) www.jcheminf.com/content/2/1/3 (1133185, 9560, X, X- R/ X/ L) dx.doi.org/10.1016/S1574-1400(08)00012-1 (1133185, -1, X, X- R/ X/ L) dx.doi.org/10.1016/j.drudis.2010.10.003 (1133185, -1, X, X- R/ X/ L) www.sciencedirect.com/science/article/pii/S1359644610007737 (1133185, -1, X, X- R/ X/ L) pubchem.ncbi.nlm.nih.gov/search/?smarts=c4ccccc4CNCC%28CO2%29Oc1c2ccc%28N3%29c1CC3%3DO (1133185, -1, X, X- R/ X/ L) www.emolecules.com/cgi-bin/search?t=ex&q=c4ccccc4CNCC%28CO2%29Oc1c2ccc%28N3%29c1CC3%3DO (1133185, 4987, X, X- R/ X/ L) www.kegg.jp/entry/D03214 (1133185, 1992, X, X- R/ X/ L) fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=Q5O76TA0ML (1133185, -1, X, X- R/ X/ L) www.chemspider.com/Chemical-Structure.139676 (1133185, -1, X, X- R/ X/ L) pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=158784 (1133185, -1, X, X- R/ X/ L) www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=189681-71-8&rn=1 (1133185, -1, X, X- R/ X/ L)

    User is in a trusted group bot on some wikis
  2. 2014-04-06 15:30:06 (UTC): w:fr:User:Bob Saint Clar ( t - c; 3500) to w:fr:Peramivir ( diff  !top) - Link: drugdiscovery.pharmaceutical-business-review.com/news/shionogi_launches_rapiacta_in_japan_100126 ( R/ Xmeta/ L)
    Other links: drugdiscovery.pharmaceutical-business-review.com/news/shionogi_launches_rapiacta_in_japan_100126 (3500, 1, 1, 0- R/ X/ L) www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm216252.htm (3500, 1314, X, X- R/ X/ L) www.nejm.org/doi/full/10.1056/NEJMp0910479 (3500, 579, 2, 0- R/ X/ L) dx.doi.org/10.1056/NEJMp0910479 (3500, -1, X, X- R/ X/ L) www.ncbi.nlm.nih.gov/pubmed/19884645 (3500, -1, X, X- R/ X/ L) www.reuters.com/article/2009/10/24/idUS10540+24-Oct-2009+PRN20091024 (3500, -1, X, X- R/ X/ L) www.fda.gov/downloads/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm187811.pdf (3500, 1314, X, X- R/ X/ L) aac.asm.org/content/54/11/4568.short (3500, 113, 4, 0- R/ X/ L) dx.doi.org/10.1128/AAC.00474-10 (3500, -1, X, X- R/ X/ L) www.ncbi.nlm.nih.gov/pmc/articles/2976170 (3500, -1, X, X- R/ X/ L) www.ncbi.nlm.nih.gov/pubmed/20713668 (3500, -1, X, X- R/ X/ L) www.chem.qmul.ac.uk/iupac/AtWt/ (3500, -1, X, X- R/ X/ L) chemapps.stolaf.edu/jmol/jmol.php?title=Peramivir&model=InChI%3D1S%2FC15H28N4O4%2Fc1-4-8%285-2%2912%2818-7%283%2920%2911-10%2819-15%2816%2917%296-9%2813%2811%2921%2914%2822%2923%2Fh8-13%2C21H%2C4-6H2%2C1-3H3%2C%28H%2C18%2C20%29%28H%2C22%2C23%29%28H4%2C16%2C17%2C19%29%2Ft9-%2C10%2B%2C11%2B%2C12-%2C13%2B%2Fm0%2Fs1 (3500, -1, X, X- R/ X/ L) chemapps.stolaf.edu/jmol/jmol.php?title=Peramivir&model=CCC%28CC%29%5BC%40%40H%5D%28%5BC%40H%5D1%5BC%40%40H%5D%28C%5BC%40%40H%5D%28%5BC%40H%5D1O%29C%28%3DO%29O%29N%3DC%28N%29N%29NC%28%3DO%29C (3500, -1, X, X- R/ X/ L) pubchem.ncbi.nlm.nih.gov/search/?smarts=CCC%28CC%29%5BC%40%40H%5D%28%5BC%40H%5D1%5BC%40%40H%5D%28C%5BC%40%40H%5D%28%5BC%40H%5D1O%29C%28%3DO%29O%29N%3DC%28N%29N%29NC%28%3DO%29C (3500, -1, X, X- R/ X/ L) pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=154234 (3500, -1, X, X- R/ X/ L)
  3. 2014-04-09 16:16:46 (UTC): w:de:User:188.96.230.236 ( t - c; 13) to w:de:Ranbaxy Laboratories ( diff  !top) - Link: www.pharmaceutical-business-review.com/companyprofile.asp?guid=07C112BA-D49F-4A9E-9EB4-1630A9D4F8E6 ( R/ Xmeta/ L)
    Other links: www.pharmaceutical-business-review.com/companyprofile.asp?guid=07C112BA-D49F-4A9E-9EB4-1630A9D4F8E6 (13, 2, 1, 1- R/ X/ L) www.indiaprwire.com/pressrelease/ranbaxy/ (13, 91, 1, 1- R/ X/ L) www.ranbaxy.com/profile.htm (13, 8, 1, 1- R/ X/ L)
  • Displayed all 3 additions.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook